Systematic Use of Telepsychiatry for Outpatients

Anxiety Disorders Clinical Trial

Official title:

Systematic Use of Telepsychiatry for Outpatients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05516238
• Other study ID #: REG-003-2021
• Status: Completed
• Phase: N/A
• Start date: April 21, 2021
• Est. completion date: April 26, 2022

Study information

• Verified date: March 2023
• Source: Psychiatric Research Unit, Region Zealand, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: April 26, 2022
• Est. primary completion date: April 26, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age > 18 years
• Danish-speaking.

Exclusion Criteria:

• Exclusion criteria included a diagnosis of schizophrenia or bipolar disorder, or suffering from substance abuse.
• Additionally, Participants in the VC group were excluded if they did not have a smartphone, tablet, laptop, or personal computer with a webcam.

Related Conditions & MeSH terms

• Anxiety Disorders
• Borderline Personality Disorder
• Depressive Disorder
• Disease
• Personality Disorders
• Ptsd

Intervention

Other:
• Case management
Case management cover therapy (psychotherapy/psychoeducation), medication adjustment, training in daily living skills (supportive), and direct consultations in crises.

Locations

Country	Name	City	State
Denmark	Psychiatric research unit, Region Zealand,	Slagelse

Sponsors (1)

Lead Sponsor	Collaborator
Psychiatric Research Unit, Region Zealand, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The demand for video consultation (VC) in clinical practice.	The demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations.	One year
Primary	Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C)	Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance	Two months.
Primary	Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8)	Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction	Two months.
Primary	Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10)	Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress	Two months.
Primary	Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5)	Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being	Two months.
Primary	Patients' function, assessed by Sheehan Disability Scale (SDS)	Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment	Two months.
Primary	Patient recovery, assessed by INSPIRE	Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery	Two months.
Primary	The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM).	The following properties are used to evaluate the implementation and integration properties: type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop); patients' physical location during VC session (Home or outdoor); the VC sessions confidentiality (Alone or with other persons); duration of VC session; the content of the VC sessions (supportive, therapy, medication management, crisis/acute or "mix" content); Descriptive statistics will be applied to evaluate the implementation and integration properties.	One year
Primary	Patients' experiences regarding the use of VC	Semistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice.	Two months